Accelerate Diagnostics Inc Quick Ratio (AXDX) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Accelerate Diagnostics Inc   (NASDAQ: AXDX)

Accelerate Diagnostics Inc 's Quick Ratio

AXDX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2024, Quick Ratio fell to 0.52 below Accelerate Diagnostics Inc average.

Within Laboratory Analytical Instruments industry 15 other companies have achieved higher Quick Ratio than Accelerate Diagnostics Inc in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 1300 to 2534.

Explain Quick Ratio?
How much Cash & cash equivalents AXDX´s has?
What are AXDX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AXDX Quick Ratio (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4
Y / Y Current Liabilities Change 159.27 % -45.23 % -78.65 % -81 % -81.09 %
Y / Y Cash & cash equivalent Change 23.28 % -1.13 % -66.72 % -46.44 % -76.1 %
Quick Ratio MRQ 0.52 1.15 0.91 1.32 1.1
AXDX's Total Ranking # 2534 # 1300 # 999 # 1011 # 1251
Seq. Current Liabilities Change 70.89 % 69.91 % -9.95 % -0.83 % -63.9 %
Seq. Cash & cash equivalent Change -22.07 % 114.57 % -38.12 % 19.15 % -37.5 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 781
Overall Market # 2534


Quick Ratio Statistics
High Average Low
81.21 9.74 0.07
(Sep 30 2013)   (Jun 30 2022)




Financial Statements
Accelerate Diagnostics Inc 's Current Liabilities $ 31 Millions Visit AXDX's Balance sheet
Accelerate Diagnostics Inc 's Cash & cash equivalent $ 16 Millions Visit AXDX's Balance sheet
Source of AXDX's Sales Visit AXDX's Sales by Geography


Cumulative Accelerate Diagnostics Inc 's Quick Ratio

AXDX's Quick Ratio for the trailling 12 Months

AXDX Quick Ratio

 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth -54.48 % -74.79 % -71.48 % -56.79 % -46.47 %
Y / Y Cash & cash equivalent TTM Growth -32.62 % -55.88 % -60.87 % -38.11 % -17.31 %
Quick Ratio TTM 0.87 1.13 0.88 0.74 0.59
Total Ranking TTM # 3691 # 3383 # 3390 # 922 # 2692
Seq. Current Liabilities TTM Growth 36.18 % -22.16 % -36.77 % -32.1 % -24.56 %
Seq. Cash & cash equivalent TTM Growth 5.16 % -0.4 % -24.6 % -14.68 % -31.15 %

Quick ratio ranking by company, industry and sector >> Back to AXDX Financial Strength Comparisons >> Go to Compare AXDX Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q4 2024 to $31.20 millions, cumulative Quick Ratio decreased to 0.87 below the Accelerate Diagnostics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Accelerate Diagnostics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 3383 to 3691.

Explain Quick Ratio?
How much Cash & cash equivalents AXDX´s has?
What are AXDX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 947
Within the Market # 3691


trailing twelve months Quick Ratio Statistics
High Average Low
28.12 9.09 0.29
(June 30. 2014)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Laboratory Analytical Instruments Industry Quick RatioDec 31 2024 MRQ Cash & cash equivalentDec 31 2024 MRQ Current Liabilities
Prenetics Global Limited  1.43 $ 52.251  Millions$ 36.551  Millions
Akoya Biosciences Inc   1.19 $ 35.040  Millions$ 29.444  Millions
Agilent Technologies inc   0.85 $ 1,329.000  Millions$ 1,556.000  Millions
Kewaunee Scientific Corporation  0.64 $ 25.938  Millions$ 40.780  Millions
Bionano Genomics Inc   0.55 $ 20.475  Millions$ 37.344  Millions
Accelerate Diagnostics Inc   0.52 $ 16.297  Millions$ 31.201  Millions
Waters Corporation  0.46 $ 325.355  Millions$ 707.789  Millions
Precipio inc   0.37 $ 1.389  Millions$ 3.714  Millions
Bruker Corporation  0.14 $ 183.400  Millions$ 1,283.800  Millions
Avantor Inc   0.13 $ 261.900  Millions$ 2,007.500  Millions
Illumina Inc   0.13 $ 93.000  Millions$ 738.000  Millions

Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.